Controllable self-assembly of RNA dendrimers

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 3, 2016, Pages 835-844

  Sharma, Ashwani ^a,b,c   Haque, Farzin ^a,b,c   Pi, Fengmei ^a,b,c   Shlyakhtenko, Lyudmila S ^e   Evers, B Mark ^b,c,d   Guo, Peixuan ^a,b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

PRNA; RNA nanoparticle; RNA nanotechnology; Three way junction

Indexed keywords

DENDRIMERS; DIAGNOSIS; DISEASE CONTROL; ELECTROPHORESIS; NANOTECHNOLOGY; SELF ASSEMBLY;

BACTERIOPHAGE PHI29; GEL ELECTROPHORESIS; MOLECULAR DIAGNOSTICS; PRNA; PROGRAMMABLE SELF ASSEMBLY; RNA NANOTECHNOLOGIES; STRUCTURAL DEFECT; THREE-WAY JUNCTION;

RNA;

DENDRIMER; RNA; RNA DENDRIMER; UNCLASSIFIED DRUG; FOLIC ACID; NANOMATERIAL; VIRUS RNA;

ARTICLE; ATOMIC FORCE MICROSCOPY; BACILLUS PHAGE PHI29; CANCER CELL; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTERNALIZATION; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; NONHUMAN; ONE POT SYNTHESIS; RNA PURIFICATION; RNA STRUCTURE; RNA SYNTHESIS; THERMODYNAMICS; THREE WAY JUNCTION; BACTERIOPHAGE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR MODEL; NANOTECHNOLOGY; NUCLEOTIDE SEQUENCE; PROCEDURES; TUMOR CELL LINE;

BACTERIOPHAGES; BASE SEQUENCE; CELL LINE, TUMOR; DENDRIMERS; FOLIC ACID; HUMANS; MODELS, MOLECULAR; NANOSTRUCTURES; NANOTECHNOLOGY; RNA, VIRAL; THERMODYNAMICS;

EID: 84960438284     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.11.008     Document Type: Article

References (56)

1. Buhleier E., Wehner W., Vogtle F. Cascade-chain-like and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis-Stuttgart 1978, 2:155-158.
2. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A 1996, 93(10):4897-4902.
3. Nilsen T.W., Grayzel J., Prensky W. Dendritic nucleic acid structures. J Theor Biol 1997, 187(2):273-284.
4. Astruc D. Electron-transfer processes in dendrimers and their implication in biology, catalysis, sensing and nanotechnology. Nat Chem 2012, 4(4):255-267.
5. Nanjwade B.K., Bechra H.M., Derkar G.K., Manvi F.V., Nanjwade V.K. Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharm Sci 2009, 38(3):185-196.
6. Hong C.A., Eltoukhy A.A., Lee H., Langer R., Anderson D.G., Nam Y.S. Dendrimeric siRNA for efficient gene silencing. Angew Chem Int Ed Engl 2015, 54(23):6740-6744.
7. Kobayashi H., Brechbiel M.W. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 2005, 57(15):2271-2286.
8. Kaminskas L.M., Boyd B.J., Porter C.J. Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. Nanomedicine (London) 2011, 6(6):1063-1084.
9. Li Y., Tseng Y.D., Kwon S.Y., D'Espaux L., Bunch J.S., McEuen P.L., et al. Controlled assembly of dendrimer-like DNA. Nat Mater 2004, 3(1):38-42.
10. Meng H.M., Zhang X., Lv Y., Zhao Z., Wang N.N., Fu T., et al. DNA dendrimer: an efficient nanocarrier of functional nucleic acids for intracellular molecular sensing. ACS Nano 2014, 8(6):6171-6181.
11. Choi Y., Baker J.R. Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer. Cell Cycle 2005, 4(5):669-671.
12. Zhou T., Wang Y., Dong Y., Chen C., Liu D., Yang Z. Tetrahedron DNA dendrimers and their encapsulation of gold nanoparticles. Bioorg Med Chem 2014, 22(16):4391-4394.
13. Zhou T., Chen P., Niu L., Jin J., Liang D., Li Z., et al. pH-responsive size-tunable self-assembled DNA dendrimers. Angew Chem Int Ed Engl 2012, 51(45):11271-11274.
14. Leontis N.B., Lescoute A., Westhof E. The building blocks and motifs of RNA architecture. Curr Opin Struct Biol 2006, 16:279-287.
15. Searle M.S., Williams D.H. On the stability of nucleic acid structures in solution: enthalpy-entropy compensations, internal rotations and reversibility. Nucleic Acids Res 1993, 21(9):2051-2056.
16. Guo P. The emerging field of RNA nanotechnology. Nat Nanotechnol 2010, 5(12):833-842.
17. Guo P., Haque F., Hallahan B., Reif R., Li H. Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology. Nucleic Acid Ther 2012, 22(4):226-245.
18. Shu Y., Pi F., Sharma A., Rajabi M., Haque F., Shu D., et al. Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Adv Drug Deliv Rev 2014, 66C:74-89.
19. Guo P., Haque F. RNA Nanotechnology and Therapeutics 2013, CRC Press, Boca Raton, FL.
20. Shukla G.C., Haque F., Tor Y., Wilhelmsson L.M., Toulme J.J., Isambert H., et al. A boost for the emerging field of RNA nanotechnology. ACS Nano 2011, 5(5):3405-3418.
21. Leontis N., Sweeney B., Haque F., Guo P. Conference scene: advances in RNA nanotechnology promise to transform medicine. Nanomedicine 2013, 8:1051-1054.
22. Shu D., Shu Y., Haque F., Abdelmawla S., Guo P. Thermodynamically stable RNA three-way junctions for constructing multifuntional nanoparticles for delivery of therapeutics. Nat Nanotechnol 2011, 6:658-667.
23. Haque F., Shu D., Shu Y., Shlyakhtenko L., Rychahou P., Evers M., et al. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today 2012, 7:245-257.
24. Shu Y., Haque F., Shu D., Li W., Zhu Z., Kotb M., et al. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA 2013, 19:766-777.
25. Guo P., Zhang C., Chen C., Trottier M., Garver K. Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Mol Cell 1998, 2:149-155.
26. Grabow W.W., Zakrevsky P., Afonin K.A., Chworos A., Shapiro B.A., Jaeger L. Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes. Nano Lett 2011, 11(2):878-887.
27. Afonin K.A., Viard M., Koyfman A.Y., Martins A.N., Kasprzak W.K., Panigaj M., et al. Multifunctional RNA nanoparticles. Nano Lett 2014, 14(10):5662-5671.
28. Khisamutdinov E.F., Jasinski D.L., Guo P. RNA as a boiling-resistant anionic polymer material to build robust structures with defined shape and stoichiometry. ACS Nano 2014, 8:4771-4781.
29. Ohno H., Kobayashi T., Kabata R., Endo K., Iwasa T., Yoshimura S.H., et al. Synthetic RNA-protein complex shaped like an equilateral triangle. Nat Nanotechnol 2011, 6(2):116-120.
30. Jasinski D., Khisamutdinov E.F., Lyubchenko Y.L., Guo P. Physicochemically tunable poly-functionalized RNA square architecture with fluorogenic and ribozymatic properties. ACS Nano 2014, 8:7620-7629.
31. Dibrov S.M., McLean J., Parsons J., Hermann T. Self-assembling RNA square. Proc Natl Acad Sci U S A 2011, 108(16):6405-6408.
32. Severcan I., Geary C., Verzemnieks E., Chworos A., Jaeger L. Square-shaped RNA particles from different RNA folds. Nano Lett 2009, 9:1270-1277.
33. Khisamutdinov E., Li H., Jasinski D., Chen J., Fu J., Guo P. Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square, and pentagon nanovehicles. Nucleic Acids Res 2014, 42:9996-10004.
34. Afonin K.A., Bindewald E., Yaghoubian A.J., Voss N., Jacovetty E., Shapiro B.A., et al. In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat Nanotechnol 2010, 5(9):676-682.
35. Geary C., Rothemund P.W., Andersen E.S. A single-stranded architecture for cotranscriptional folding of RNA nanostructures. Science 2014, 345:799-804.
36. Guo P., Erickson S., Anderson D. A small viral RNA is required for in vitro packaging of bacteriophage phi29 DNA. Science 1987, 236:690-694.
37. Binzel D.W., Khisamutdinov E.F., Guo P. Entropy-driven one-step formation of Phi29 pRNA 3WJ from three RNA fragments. Biochemistry 2014, 53(14):2221-2231.
38. Lee T.J., Haque F., Shu D., Yoo J.Y., Li H., Yokel R.A., et al. RNA nanoparticles as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget 2015, 6:14766-14776.
39. Rychahou P., Haque F., Shu Y., Zaytseva Y., Weiss H.L., Lee E.Y., et al. Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano 2015, 9(2):1108-1116.
40. Abdelmawla S., Guo S., Zhang L., Pulukuri S., Patankar P., Conley P., et al. Pharmacological characterization of chemically synthesized monomeric pRNA nanoparticles for systemic delivery. Mol Ther 2011, 19:1312-1322.
41. Cui D., Zhang C., Liu B., Shu Y., Du T., Shu D., et al. Regression of gastric cancer by systemic injection of RNA nanoparticles carrying both ligand and siRNA. Sci Rep 2015, 5:10726.
42. Shu D., Li H., Shu Y., Xiong G., Carson W.E., Haque F., et al. Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology. ACS Nano 2015, 9:9731-9740.
43. Lee T., Yagati A.K., Pi F., Sharma A., Chio J.W., Guo P. Construction of RNA-quantum dot chimera for nanoscale resistive biomemory application. ACS Nano 2015, 9:6675-6682.
44. Zhang H., Endrizzi J.A., Shu Y., Haque F., Sauter C., Shlyakhtenko L.S., et al. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the phi29 hexameric motor pRNA. RNA 2013, 19:1226-1237.
45. Li H., Lee T., Dziubla T., Pi F., Guo S., Xu J., et al. RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications. Nano Today 2015, 10:631-655.
46. Shu Y., Shu D., Haque F., Guo P. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nat Protoc 2013, 8(9):1635-1659.
47. Lyubchenko Y.L., Shlyakhtenko L.S., Ando T. Imaging of nucleic acids with atomic force microscopy. Methods 2011, 54:274-283.
48. Zuker M. Mfold Web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003, 31(13):3406-3415.
49. Behlke M.A. Chemical modification of siRNAs for in vivo use. Oligonucleotides 2008, 18(4):305-319.
50. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11(9):597-610.
51. Liu J., Guo S., Cinier M., Shlyakhtenko L.S., Shu Y., Chen C., et al. Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging. ACS Nano 2011, 5(1):237-246.
52. Helmling S., Moyroud E., Schroeder W., Roehl I., Kleinjung F., Stark S., et al. A new class of Spiegelmers containing 2'-fluoro-nucleotides. Nucleosides Nucleotides Nucleic Acids 2003, 22:1035-1038.
53. Advanced Drug Delivery Reviews: Cancer Nanotechnology 2014, 66. Elsevier. P. Grodzinski, V. Torchilin (Eds.).
54. Parker N., Turk M.J., Westrick E., Lewis J.D., Low P.S., Leamon C.P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 2005, 338(2):284-293.
55. Sugimoto N., Nakano S., Katoh M., Matsumura A., Nakamuta H., Ohmichi T., et al. Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry 1995, 34(35):11211-11216.
56. Rauzan B., McMichael E., Cave R., Sevcik L.R., Ostrosky K., Whitman E., et al. Kinetics and thermodynamics of DNA, RNA, and hybrid duplex formation. Biochemistry 2013, 52(5):765-772.